Investor Presentaiton
Long-term incentive and director compensation plans
Stock option and RSU transactions under our long-term incentive and director compensation plans are as follows:
RSUS
Weighted Average
Stock Options
Shares
Weighted Average
Exercise Price
per Share
Outstanding grants, December 31, 2015
56,773,983
$ 37.45
Shares
16,055,542
Grant Date Fair
Value per Share
$ 38.51
Granted
10,974,304
53.02
2,337,976
53.98
Vested RSUs
-
(5,639,666)
31.64
Forfeited and expired
Exercised
(965,893)
(14,516,606)
48.12
(421,473)
42.63
32.51
Outstanding grants, December 31, 2016
52,265,788
41.89
12,332,379
44.44
FORM 10-K
The weighted average grant date fair values per share of RSUs granted in 2016, 2015 and 2014 were $53.98, $53.22 and $44.71,
respectively. In 2016, 2015 and 2014, the total grant date fair values of shares vested from RSU grants were $178 million,
$114 million and $133 million, respectively.
Summarized information about stock options outstanding as of December 31, 2016, is as follows:
Exercise Price Range
$14.47 to 20.00
Number
Outstanding
(Shares)
1,996,801
5,130,177
Stock Options Outstanding
Weighted Average
Remaining Contractual
Life (Years)
2.1
Weighted Average
Exercise Price per
Share
$ 14.96
24.59
Options Exercisable
Weighted Average
Exercise Price per
Number
Exercisable
(Shares)
1,996,801
5,130,177
11,328,597
Share
$ 14.96
24.59
ITTAT
20.01 to 30.00
2.6
30.01 to 40.00
14,126,454
5.3
40.01 to 50.00
50.01 to 60.00
9,854,196
21,103,396
7.1
33.06
44.10
8.6
53.44
3,544,639
2,017,172
33.12
44.10
53.96
60.01 to 71.27
54,764
9.7
71.00
14.47 to 71.27
52,265,788
6.6
41.89
24,017,386
33.16
In 2016, 2015 and 2014, the aggregate intrinsic values (i.e., the difference in the closing market price on the date of exercise and
the exercise price paid by the optionee) of options exercised were $424 million, $290 million and $367 million, respectively.
Summarized information as of December 31, 2016, about outstanding stock options that are vested and expected to vest, as well
as stock options that are currently exercisable, is as follows:
Number of outstanding (shares)
Weighted average remaining contractual life (in years)
Weighted average exercise price per share
Intrinsic value (millions of dollars)
Outstanding Stock Options
(Fully Vested and
Expected to Vest) (a)
Options
Exercisable
50,994,139
6.5
24,017,386
4.9
$
41.63
1,598
ᏌᏊ Ꮚ
33.16
956
(a) Includes effects of expected forfeitures of approximately 1 million shares. Excluding the effects of expected forfeitures, the
aggregate intrinsic value of stock options outstanding was $1,624 million.
As of December 31, 2016, the total future compensation cost related to equity awards not yet recognized in our Consolidated
Statements of Income was $250 million, consisting of $111 million related to unvested stock options and $139 million related to
unvested RSUs. The $250 million is expected to be recognized as follows: $129 million in 2017, $80 million in 2018, $37 million in
2019 and $4 million in 2020.
40
40
TEXAS INSTRUMENTS . 2016 FORM 10-KView entire presentation